EndoGastric Solutions is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/25/2020 | Series J | $27MM | $xx.xx | $448.42MM | Vertex Growth Fund | |
Price per Share
$xx.xx
Shares Outstanding
10,751,404
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
2.9%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Vertex Growth Fund
|
||||||
05/28/2019 | Series I | $45MM | $xx.xx | $380.74MM | Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, Crg, Radius Ventures, Sightline Partners | |
Price per Share
$xx.xx
Shares Outstanding
19,710,907
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
3.2%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, Crg, Radius Ventures, Sightline Partners
|
||||||
07/10/2018 | Series H | $15.2MM | $xx.xx | $138.45MM | Advanced Technology Ventures, Canaan Partners, Canepa Healthcare, Chicago Growth Partners, Crg, Radius Ventures, Sightline Partners | |
Price per Share
$xx.xx
Shares Outstanding
16,641,936
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Canaan Partners, Canepa Healthcare, Chicago Growth Partners, Crg, Radius Ventures, Sightline Partners
|
||||||
05/06/2014 | Series G-1 | $9.43MM | $xx.xx | $196.98MM | Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,322,523
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
|
||||||
05/06/2014 | Series G | $20.46MM | $xx.xx | $196.98MM | Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures | |
Price per Share
$xx.xx
Shares Outstanding
22,399,660
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
|
||||||
06/21/2012 | Series F | $37.17MM | $xx.xx | $146.9MM | Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures | |
Price per Share
$xx.xx
Shares Outstanding
40,700,693
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors, Radius Ventures
|
||||||
11/25/2009 | Series E | $15.26MM | $xx.xx | $109.8MM | Advanced Technology Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,391,061
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures
|
||||||
08/31/2007 | Series D | $8.54MM | $xx.xx | $98.28MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,126,926
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
02/23/2006 | Series C | $8.89MM | $xx.xx | $59.62MM | Chicago Growth Partners | |
Price per Share
$xx.xx
Shares Outstanding
6,041,662
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chicago Growth Partners
|
||||||
09/11/2004 | Series B | $1.31MM | $xx.xx | $11.18MM | Advanced Technology Ventures, Foundation Medical Partners, Mpm Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,399,998
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Foundation Medical Partners, Mpm Capital
|
||||||
04/08/2003 | Series A | $737,298.00 | $xx.xx | $4.92MM | Advanced Technology Ventures, Foundation Medical Partners, Mpm Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,683,329
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advanced Technology Ventures, Foundation Medical Partners, Mpm Capital
|